½²ÄR®S°Æ°õ¦æªø¶i¤@¨Bªí¥Ü¡A¤µ¦~°·«OÁ`ÃB¬ð¯}8000»õ¤jÃö¡A¹F8095.62»õ¤¸¡A¸û¥h¦~¬ù¼W¥[¤F260»õ¤¸¡A¦¨ªø²v¬°3.32%¡A¦ý¦^ÅU¹L¥h´X¦~°·«OÁ`ÃBªº¦¨ªø²v¤j·§¦b4~5¢H¡AµM¦ÓÀù¯gÃĶO¨C¦~¦¨ªø´T«×¬ù10%¡A¤ñ°·«OÁ`ÃBªº¦¨ªø²v°ª¥X¤@¿¡A§Y¨Ï¥h¦~ªì°·«O¶O²v½Õº¦±q4.69% ¦Ü²{¦æªº5.17%¡A¹ï°·«O°]¬Fµ²ºc¤´¬Oªv¼Ð¤£ªv¥»¡A³o¾ÉP°·«O¼fij±o¦b¥ÃÄò¸gÀç»P¯f¤ÍªvÀøÅv¯q¤§¶¡°µ¥XÁ}§xªº¿ï¾Ü¡C¦Ó¯¸¦b¥H¯f¤Í¬°¤¤¤ßªº«äºû¡A¥²¶·§ó«e¤«ä¦Ò¶W°ªÄÖªÀ·|»P·sÃÄ·s¬ì§Þ§Ö³t¶i®iªº½ÄÀ»¡A¬O§_¦³¤@¹L´ç«¬¤ä«ù¾÷¨î¡A¦b±Ï«æ±Ï©Rªº¦P®É¡A´î»´Àù¯g®a®xªº¦Û¶Ot¾á¡A´£¤ÉÀù¯g·sÃĪº¥iªñ©Ê¡C
¸g¹L¤T¦~¦hªº¬ã¨s¡A¥xÆWÀù¯g°òª÷·|»P¦hÓ¯f¤Í¹ÎÅé´£¥X¡u¥xÆWÀù¯g·sÃĦh¤¸¤ä«ù°òª÷¡]Taiwan multi-support Cancer Drug Fund, TmCDF¡^¡A¨Ã©ó¤é«e¦V¬F©²´£¥æ¬Fµ¦«Ø¨¥®Ñ¡A§Æ¾¬¦³Ãö³æ¦ì¯à°Ñ±Ä¡C½²ÄR®S°Æ°õ¦æªø»¡¡A¥xÆWÀù¯g·sÃĦh¤¸¤ä«ù°òª÷¬O¦b¥þ¦³¡B¥þµL¤§¶¡¡A©ó°·«OÅé¨î¥~¡A¥HÃB¥~°]·½¤ä«ùÀù¯g·sÃĪº°òª÷¡A¿Ä¤J¦h¤¸°Ñ»P¡A¦P®ÉÝÅU·ÓÅU¸gÀÙ®z¶Õ¯f¤Í¡A¨Ã½T«O°·«O¥ÃÄòµo®i¡C
©IÆ~¬F©²±À°Ê¡u¥xÆWÀù¯g·sÃĦh¤¸¤ä«ù°òª÷TmCDF¡vÅýÀù¯g·sÃħó¥iªñ¡C¥xÆW¦~»´¯f¤Í¨ó·|²z¨Æªø¼ï©É§D«ü¥X¡A20-64·³¬O¥xÆW«nªº¸gÀٳҰʤO¡A¤]¬O®a®xªº«n¸gÀÙ¤ä¬W¡A´£¨ÑÀø®Ä§ó¦n¡B°Æ§@¥Î§ó§CªºÀù¯g·sÃÄ¡A§ïµ½¦s¬¡´Á¡Aªø´Áéw±±¨î¯f±¡¡AÅýÀù¤Í¥i¥H¦^¨ì¾³õ¡A¦^Âk¥¿±`¥Í¬¡¡A¬O·í°È¤§«æ¡A´Á«Ý¥¼¨ÓÂÇTmCDF°òª÷ªº³]¥ß¡A«O»ÙªÀ·|¤¤°í¥÷¤lªº¸gÀ٥Ͳ£¤O¡C
¥»¤å¸g °·±dÂåÀøºô ±ÂÅv¥Zµn¡Aì¤åµoªí
©ó¦¹
¡i°·±dÂåÀøºô¡þ°OªÌ·¨¦ã®x³ø¾É¡j2022/03/30